Algeta is developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform.
Business Model:
Revenue: $0
Employees: 10,001-1
Address: Kjelsåsveien 172 A
City: Oslo
State: oslo
Zip: 0411
Country: NO
Algeta is developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform.
Contact Phone:
Contact Email:
Listed Exchange:
NYSE
IPO Date:
3/27/2007
Ticker Symbol:
ALGZF
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2012 | Post-IPO Equity | $45M | 9/2005 | Series A | 5 | $28.9M |
Advent Life Sciences SR One Advent Venture Partners NorgesInvestor HealthCap Advent Life Sciences SR One Advent Venture Partners NorgesInvestor HealthCap |
2/2009 | Post-IPO Equity | 1 | $35M |
Abingworth Abingworth |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|